We have used salicylhydroxamic acid (SHAM) to inhibit intraphagosomal myeloperoxidase activity in order to evaluate the role of this enzyme in the killing of Staphylococcus aureus by human neutrophils. 50 PM-SHAM reduced the luminol-dependent chemiluminescence response stimulated during phagocytosis of unopsonized latex beads and opsonized S . aureus by over 80% and 60%, respectively. When opsonized S . aureus were incubated with neutrophils, 45% were killed within 15 min incubation and 60% by 1 h. However, in neutrophil suspensions incubated with 50 PM-SHAM, only 13% were killed by 15 min whilst 71 % still remained viable after 1 h. This inhibitor had no effect upon the number of bacteria phagocytosed or upon degranulation. In a cell-free system, 2.5 pM-H20, alone killed 55% of the bacteria, whereas in the presence of myeloperoxidase (i.e. 10 mU myeloperoxidase and 2.5 pM-H202) virtually all of the bacteria were killed : the addition of 50 VM-SHAM abolished this myeloperoxidase-enhanced killing but did not affect the H202-dependent killing. We therefore conclude that in normal neutrophils whilst H 2 0 2 is required for killing of this pathogen, both myeloperoxidase-dependent and -independent pathways exist.
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This inhibitor had no effect upon the number of bacteria phagocytosed or upon degranulation. In a cell-free system, 2.5 pM-H20, alone killed 55% of the bacteria, whereas in the presence of myeloperoxidase (i.e. 10 mU myeloperoxidase and 2.5 pM-H202) virtually all of the bacteria were killed : the addition of 50 VM-SHAM abolished this myeloperoxidase-enhanced killing but did not affect the H202-dependent killing. We therefore conclude that in normal neutrophils whilst H 2 0 2 is required for killing of this pathogen, both myeloperoxidase-dependent and -independent pathways exist.
I N T R O D U C T I O N
In order to carry out their important role in host defence, polymorphonuclear leucocytes (neutrophils) possess a battery of cytotoxic enzymes and associated pathways which can be utilized for microbial killing. These may be classified as those whose activity is either dependent or independent of the requirement for molecular 02. The latter group includes the activities of proteases, defensins, permeability-inducing proteins and lysozyme (Elsbach & Weiss, 1983 ; Spitznagel, 1984; Ganz et al., 1985) . 02-dependent processes result in the generation of a series of reactive oxygen metabolites (e.g. O,, H 2 0 2 , .OH, HOC1, and l o 2 ) during a respiratory burst of non-mitochondria1 O2 uptake (Babior, 1978 (Babior, , 1984 . The possession of such a diverse array of bactericidal systems with different biochemical modes of action is necessary to ensure the maximal killing potential against a wide range of pathogens which may themselves show resistance to any one particular system. Indeed, experimental evidence has confirmed this selective toxicity: bacterial-permeability-inducing peptide preferentially kills Gram-negative bacteria such as Escherichia coli and Salmonella typhimurium (Elsbach & Weiss, 1983) , defensins are toxic to Cryptococcus neoformans and Pseudomonas aeruginosa (Ganz et al., 1985) and the efficient killing of Staphylococcus aureus requires the activation of 0,-dependent processes (Edwards et al., 1987 (Edwards et al., , 1988a .
The generation of a full complement of reactive oxidants by neutrophils requires the activities of two enzyme systems. Firstly, a plasma-membrane-bound NADPH oxidase is activated to produce 0, and H 2 0 2 during the respiratory burst (Rossi, 1986) and, secondly, myeloperoxidase (an enzyme normally located within azurophilic granules and discharged to the site of oxidant generation by the process of degranulation; Klebanoff & Clark, 1978) , may react with H 2 0 2 and possibly 0, to produce HOCl and related compounds (Harrison & Schultz, 1976) . Since its discovery, myeloperoxidase has been shown to possess peroxidase, catalase, superoxide dismutase, oxidase and DNA-binding activities (Winterbourne et al., 1985; Cuperus et al., 1986; Edwards & Lloyd, 1987; Murao ut al., 1988) and, in vitro, the myeloperoxidase-H202-halide system has potent antibacterial, antifungal, antiviral and antitumour properties (Klebanoff & Clark, 1978) . However, the role of this enzyme in bacterial killing has recently been questioned because of the finding that neutrophils from apparently healthy individuals may be deficient in this enzyme (Lehrer & Cline, 1969; Salmon et al., 1970; Klebanoff & Pincus, 1971 ; Nauseef, 1988) . The degree of this deficiency varies but it must be borne in mind that in normal neutrophils this enzyme may constitute 5% of the total protein (Klebanoff & Clark, 1978 Nauseef, 1988) .
Since it has been proposed that in myeloperoxidase-deficient neutrophils other bactericidal systems are elaborated (Klebanoff & Pincus, 1971 ; Kitahara et al., 1981) , and also that a specific inhibitor does not exist (Edwards & Swan, 1986) , definition of the role of this enzyme in microbial and tumour cell killing by normal neutrophils has not as yet been possible. The most commonly used myeloperoxidase inhibitor in neutrophil studies is sodium azide, but since this is a non-specific haem inhibitor and also quenches -OH and lo2 (Halliwell & Gutteridge, 1985) , its broad toxicity renders it useless for cytotoxicity studies. We have recently shown that salicylhydroxamic acid (SHAM), previously used as an inhibitor of the alternative cyanideinsensitive oxidase of plant mitochondria (Schonbaum et d., 1971) and some other redox enzymes (Rich et al., 1978) , is a potent inhibitor of the myeloperoxidase system (Davies & Edwards, 1989) . The aim of the present study was to use this inhibitor to establish the role of myeloperoxidase in the killing of S . aureus by normal human neutrophils.
M E T H O D S
Isolation and preparation of neutrophils. Polymorphonuclear leucocytes (neutrophils) were isolated from heparinized venous blood from healthy volunteers utilizing either a dextran/Ficoll sedimentation procedure (Edwards 8c Swan, 1986) or Mono-Poly Resolving Medium (Flow Laboratories) as described previously (Edwards et af., 1987) . After purification, cells were suspended in a buffer containing (mM): NaC1, 120; KC1,4.8; KH2P04, 1.2; CaCl,, 1.3; MgS04, 1.2; HEPES, 25 (pH 7.4): and 0.1 %bovine serum albumin. Neutrophils (>98% purity) were counted using a Fuchs-Rosenthal haemocytometer slide and used within 4 h of preparation.
Bactericidal assays. Staphylococcus aureus (Oxford) was grown overnight on nutrient agar plates and then opsonized with 10% (v/v) pooled normal human serum by the method of Turner et af. (1986) as described in detail by Edwards er al.
(1 987). After opsonization, unbound proteins were removed by centrifugation and bacteria were suspended in sterile buffer at known concentrations. Opsonized bacteria (3 x lo7 ml-l) were incubated with neutrophil suspensions (lo6 ml-I) with gentle agitation in the presence or absence of SHAM at the stated concentration, and at suitable time intervals samples were removed for the estimation of viable bacteria as described previously (Edwards et a f . , 1987) . Alternatively, opsonized bacteria were incubated in a cell-free myeloperoxidase/H20, system (Klebanoff, 1968) containing 2.5 ~M-H,O, and 120 mM-CI-in the presence or absence of 10 mU purified myeloperoxidase and 50 PM-SHAM. Viable bacteria were then estimated after 30 min incubation.
Analytical methods. Chemiluminescence was measured using an LKB Wallac 1250 luminometer in neutrophil suspensions containing lo6 cells ml-l and 10 p-luminol: suspensions were stimulated by the addition Of 4 x lo9 latex beads ml-' (1.01 pm diameter) or opsonized bacteria (3 x lo7 ml-I) in the presence or absence of SHAM at the stated concentration. Human myeloperoxidase was purified from buffy coats as described by Pember et al. (1983) and had an A430/A2so ratio of 0.68.
Electron microscopy. Neutrophils incubated with opsonized S . aureus in the presence or absence of 50 PM-SHAM for 20 min at 37 "C were fixed in cold 0.15 M-cacodylate-buffered glutaraldehyde, pH 7.4 (2.5%, v/v) and post-fixed with osmium tetroxide (1 %, v/v). The mixtures were embedded in Araldite, thin-sectioned and stained with Reynold's lead citrate and uranyl acetate (1 %, w/v). Thin sections were examined using a Philips 301 electron microscope.
Statistical analysis. Data were compared using Student's t-test. Chemicals. Luminol, HEPES and SHAM were from Sigma. All other chemicals were of the highest purity available.
R E S U L T S A N D DISCUSSION

Efect of SHAM on chemiluminescence during phagocytosis
In order to establish that SHAM permeated neutrophils and inhibited myeloperoxidase activity within phagolysosomes, neutrophils were incubated with various concentrations of inhibitor and the chemiluminescence stimulated upon phagocytosis was measured. As shown in Fig. 1 , 50 PM-SHAM inhibited the chemiluminescence stimulated during phagocytosis of opsonized S . aureus by over 60% and that measured during phagocytosis of unopsonized latex beads by over 80%. Since SHAM did not inhibit uptake of particles (see later) and as it has no inhibitory effect on oxidant generation (Davies & Edwards, 1989) , these data show that this compound effectively inhibited the intraphagosomal activity of myeloperoxidase after both receptor-dependent and -independent uptake of particles.
Eflect of SHAM on the killing of S . aureus by neutrophils
Since 50 PM-SHAM resulted in considerable inhibition of intraphagosomal myeloperoxidase activity (Fig. l) , we determined whether this inhibition resulted in impaired bactericidal activity towards S . aureus. Neutrophil suspensions were incubated with opsonized S . aureus in the presence or absence of 50 PM-SHAM. At suitable time intervals after the addition of luminol and bacteria, portions were removed for estimation of viable bacteria (after lysis of neutrophils) and measurement of chemiluminescence (Fig. 2) . In control suspensions the bacteria were rapidly killed during phagocytosis ; in suspensions treated with 50 PM-SHAM, killing was clearly reduced. For example, after 15 min incubation with the inhibitor, 87% ( & 10; mean & SD, n = 7) remained viable, compared to 56% ( f 9, n = 9) in the control, and by 60 min 71 % were viable ( & 11, n = 10) compared to 43% (& 8, n = 10) in control suspensions. Control experiments showed that this concentration of inhibitor alone had no effect on the viability of the bacteria.
Luminol-dependent chemiluminescence traces obtained from these experiments are shown in Fig. 3 . In control suspensions the maximum rate of increase in chemiluminescence occurred within the first 15-20min (corresponding to the time of greatest killing) and then slowly declined over the remainder of the experiment after reaching a maximum value of about 70 mV. In identical suspensions treated with 50 PM-SHAM, the maximum rate of chemiluminescence was 15 mV at 20 min and after this time the rate slowly declined.
Samples were fixed with glutaraldehyde 30 min after phagocytosis of S . aureus and electron micrographs analysed in order to assess whether SHAM had any effect upon the rate of particle uptake or degranulation. Enumeration of intracellular, phagocytosed bacteria in these micrographs revealed no significant difference in the rate of particle uptake in control (7.6 & 4.9 bacteria per neutrophil; mean f SD, n = 101 neutrophils counted) or SHAM-treated suspensions (7.6 f 4.2 bacteria per neutrophil, n = 102 neutrophils counted). Furthermore, these experiments showed that migration of granules towards the phagosome and degranulation were not affected by treatment with this compound (Fig. 4) . Thus, we attribute the reduced killing (Fig. 2) to inhibition of myeloperoxidase and not to any effect of SHAM on phagocytosis or degranulat ion.
Efect of SHAM on the killing of S . aureus by a cell-free myeloperoxidaselH202 system
We have previously shown that SHAM has no effect on the kinetics of oxidant generation during the respiratory burst (Davies & Edwards, 1989) . However, in order to exclude the possibility that this compound affected H202-dependent (but myeloperoxidase-independent) killing of S . aureus, the killing of opsonized bacteria in a cell-free myeloperoxidase/H202 system (see Methods) was examined. When opsonized bacteria were incubated with 2.5 ~M -H~O~ alone, 55% (t 20; mean 2 SEM, n = 8) of the bacteria were killed within 30 min incubation. In suspensions containing 10 mU purified myeloperoxidase plus 2.5 pM-H,O2, considerably more bacteria were killed (95% & 19, n = 1 l), i.e. the purified enzyme enhanced H202-dependent killing of this organism. However, in suspensions containing 10 mU purified myeloperoxidase, 2.5 pM-H202 plus 50 p~-S H A M , the level of killing (44% & 7, n = 9) was similar to that observed by H 2 0 2 alone, i.e. the inhibitor abolished the myeloperoxidase-enhanced killing.
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The results of these experiments are consistent with previous reports regarding the mechanisms of killing of S . aureus by human neutrophils and show several important features. Fig. 4 . Electron micrograph of ingested S . aureus. Neutrophils were incubated as described in the legend to Fig. 2 . After 20 min incubation with opsonized S . aureus, suspensions were fixed with glutaraldehyde as described in Methods. After embedding, sectioning and staining at least 100 neutrophils from control or SHAM-treated suspensions were examined and the numbers of ingested bacteria counted. The figure shows a section of a neutrophil that had been incubated with 50 PM-SHAM before the addition of bacteria. Bar, 1 pm.
Firstly, H 2 0 2 (in the absence of myeloperoxidase) is capable of killing this pathogen. Secondly, the H202-dependent killing of this organism is considerably enhanced by the presence of myeloperoxidase. Thirdly, oxygen-independent granule enzymes do not play a role in this killing process since neutrophils from patients with chronic granulomatous disease cannot kill this pathogen (Edwards et al., 1987) : the only biochemical defect in these patients is their inability to generate reactive oxidants (Tauber et al., 1983) . Thus, we confirm that the efficient killing of S . aureus by human neutrophils requires the activation of oxygen-dependent processes (Edwards et al., 1987 (Edwards et al., , 1988a ) but now show that both myeloperoxidase-dependent and -independent pathways exist.
SHAM can act as a peroxidase inhibitor and (at a concentration of 5 0~~) scavenge the myeloperoxidase product HOCl (Davies & Edwards, 1989) . Therefore, its ability to reduce bacterial killing may reside in its ability to either inhibit the enzymic activity of myeloperoxidase or else scavenge one of its major products, or a combination of these two effects. The use of SHAM as an inhibitor of myeloperoxidase has, for the first time, enabled the role of this enzyme in S . aureus killing by normal neutrophils to be evaluated. The data presented here confirm the observations of experiments with myeloperoxidase-deficient neutrophils which could not kill this pathogen as efficiently as controls (Kitahara et al., 1981 ; Lanza et al., 1987) . Thus, by virtue of its non-toxicity towards the target cell, SHAM is a powerful analytical tool which can now be used to delineate the function of myeloperoxidase in other inflammatory events.
